Adaptimmune Therapeutics
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Adaptimmune Therapeutics's balance sheet done over the years? Its assets were worth $282,616,000 last year, which is less than in the previous period. 86% of Adaptimmune Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $243,103,000, which means an decrease by -2% compared compared to last year.
Debt to Assets
| 2014 | 55518275 | 53.10M | 95.66% |
|---|---|---|---|
| 2015 | 300677747 | 41.06M | 13.66% |
| 2016 | 234515000 | 68.37M | 29.16% |
| 2017 | 281147000 | 78.16M | 27.8% |
| 2018 | 276736000 | 29.85M | 10.79% |
| 2019 | 181543000 | 57.90M | 31.9% |
| 2020 | 451142000 | 109.91M | 24.36% |
| 2021 | 469545000 | 263.58M | 56.14% |
| 2022 | 328916000 | 247.03M | 75.11% |
| 2023 | 282616000 | 243.10M | 86.02% |
ADAP Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 143.99M | 108.03M | 149.94M | 56.88M | 50.41M | 68.37M | 84.04M | 158.77M | 229.05M | 51.27M |
Short term investments | 2.94M | 96.57M | 219.63M | 311.33M | 39.13M | 136.75M | 124.21M | 22.69M | 55.29M | 0 |
Net receivables | 46.91M | 7.43M | 752K | 139K | -1.45M | 192K | 206K | 1.48M | 5.44M | 4K |
Inventory | 0 | 1.27M | 746K | 2.08M | 1.45M | 1.08M | 3.76M | 0 | 102.21K | 1 |
Other current assets | 13.69M | 43.33M | 45.12M | 29.79M | 30.94M | 25.76M | 24.07M | 15.79M | 5.20M | 10.63M |
Total current assets | 207.55M | 255.37M | 415.45M | 398.15M | 120.48M | 231.09M | 230.18M | 198.75M | 295.10M | 54.08M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 71.70M | 71.53M | 51.36M | 46.65M | 51.85M | 36.11M | 40.67M | 27.89M | 5.39M | 1.43M |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 330K | 442K | 1M | 1.73M | 2.19M | 1.47M | 1.33M | 1.26M | 177.69K | 0 |
Long term investments | 0 | 1.56M | 1.71M | 4.60M | 4.49M | 0 | 4.25M | 0 | 4.48M | 0 |
Other non-current assets | 3.02M | 1.56M | 1.71M | 4.60M | 6.99M | 8.05M | 8.94M | 6.59M | 4.70M | 0 |
Total non-current assets | 75.06M | 73.54M | 54.08M | 52.99M | 61.05M | 45.64M | 50.96M | 35.76M | 5.56M | 1.43M |
Total assets | 282.61M | 328.91M | 469.54M | 451.14M | 181.54M | 276.73M | 281.14M | 234.51M | 300.67M | 55.51M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 28.97M | 23.52M | 22.19M | 2.83M | 2.12M | 0 | 38.73M | 11.39M | 20.90M | 0 |
Short term debt | 10.76M | 2.72M | 2.32M | 2.77M | 2.49M | 0 | 0 | 16.44M | 1 | 0 |
Total current liabilities | 72.78M | 64.50M | 62.54M | 39.07M | 34.34M | 24.43M | 74.31M | 40.27M | 26.75M | 53.10M |
| Non-current liabilities: | ||||||||||
Long term debt | 39.70M | 20.34M | 23.14M | 20.93M | 22.96M | 0 | 0 | 0 | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | -18.44M | 1.29M | 673K | 644K | 598K | 3.99M | 3.84M | 3.14M | -12.18M | 0 |
Total non-current liabilities | 170.31M | 182.53M | 201.04M | 70.84M | 23.56M | 5.41M | 3.84M | 28.10M | 14.30M | 1.01M |
Total liabilities | 243.10M | 247.03M | 263.58M | 109.91M | 57.90M | 29.85M | 78.16M | 68.37M | 41.06M | 53.10M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |